Lv2
104 积分 2024-08-26 加入
Therapeutic Strategies to Target the Androgen Receptor
21天前
已完结
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
21天前
已完结
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
21天前
已完结
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
21天前
已完结
RECENT ADVANCES IN TARGETING THE ANDROGEN RECEPTOR WITH PROTACS
21天前
已关闭
Synthesis and Biological Evaluation of Second-Generation Tropanol-Based Androgen Receptor Modulators
1个月前
已完结
Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer
1个月前
已完结
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists
1个月前
已完结
(+)-(2R,5S)-4-[4-Cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an Orally Potent and Peripherally Selective Nonsteroidal Androgen Receptor Antagonist
1个月前
已完结
Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
1个月前
已完结
皖公网安备34019202002308
